These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1621 related articles for article (PubMed ID: 15872200)
1. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200 [TBL] [Abstract][Full Text] [Related]
2. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer. Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904 [TBL] [Abstract][Full Text] [Related]
3. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928 [TBL] [Abstract][Full Text] [Related]
4. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X; JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432 [TBL] [Abstract][Full Text] [Related]
6. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Berginc G; Bracko M; Ravnik-Glavac M; Glavac D Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325 [TBL] [Abstract][Full Text] [Related]
7. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
9. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860 [TBL] [Abstract][Full Text] [Related]
10. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786 [TBL] [Abstract][Full Text] [Related]
11. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491 [TBL] [Abstract][Full Text] [Related]
12. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158 [TBL] [Abstract][Full Text] [Related]
13. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451 [TBL] [Abstract][Full Text] [Related]
14. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329 [TBL] [Abstract][Full Text] [Related]
15. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044 [TBL] [Abstract][Full Text] [Related]
16. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related]
17. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. Barnetson RA; Tenesa A; Farrington SM; Nicholl ID; Cetnarskyj R; Porteous ME; Campbell H; Dunlop MG N Engl J Med; 2006 Jun; 354(26):2751-63. PubMed ID: 16807412 [TBL] [Abstract][Full Text] [Related]
18. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982 [TBL] [Abstract][Full Text] [Related]
19. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Ponz de Leon M; Benatti P; Di Gregorio C; Pedroni M; Losi L; Genuardi M; Viel A; Fornasarig M; Lucci-Cordisco E; Anti M; Ponti G; Borghi F; Lamberti I; Roncucci L Br J Cancer; 2004 Feb; 90(4):882-7. PubMed ID: 14970868 [TBL] [Abstract][Full Text] [Related]
20. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]